Global Clinical Trials for COVID-19: Summary of Antiviral and Vaccine Therapies in Pursuit of Regulatory Approval to Treat COVID-19

DUBLIN, May 18, 2020 /PRNewswire/ -- The "Clinical Trial Report COVID-19 Special Edition" report has been added to's offering.

The cataclysm caused by the COVID-19 pandemic has impacted on clinical trials in terms of alternatives for study participants, enhanced operational and financial support for progressively more complex trial protocol designs, and greater collaboration among sponsors.

Therefore, presented here is a timely summarised report of new candidate antiviral and vaccine therapies undergoing clinical trials worldwide in the pursuit of gaining regulatory approval for treatment and/or prophylaxis against SARS-CoV-2 coronavirus infection.

Countries Covered:

    --  China
    --  EU
    --  South Korea
    --  US

Products Mentioned:

    --  INO-4800 Vaccine
    --  BNT162 Vaccine
    --  NP-120 (Ifenprodil)
    --  Vafidemstat
    --  IPH5401 (Avdoralimab)
    --  mRNA-1273 Vaccine
    --  Dociparstat Sodium (DSTAT)
    --  Ryoncil (Remestemcel-L)
    --  Pacritinib
    --  NT-300 (Nitazoxanide extended-release tablets)

Companies Mentioned

    --  Algernon
    --  BioNTech
    --  CTI BioPharma
    --  Chimerix
    --  Genomics
    --  Innate
    --  Inovio
    --  Mesoblast
    --  Moderna
    --  ORYZON
    --  Pfizer
    --  Pharma
    --  Pharmaceuticals
    --  Romark Labs

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets